Published 14:03 IST, February 9th 2024
Zydus Lifesciences Q3 profit beats estimates; announces share buyback
Zydus Lifesciences announced the approval of a shares buyback programme worth Rs 600 crore via tender offer route.
Top 10 Pharmaceutical Companies in India by Market Capitalisation | Image:
Unsplash
Advertisement
14:03 IST, February 9th 2024